Costly drugs to weigh on U.S. employers` expenses in 2018: survey

Published 7y ago

U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer. More »